Agilent Technologies (A) vs IQVIA (IQV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
IQVIA (IQV) has outperformed Agilent Technologies (A) over the past year, gaining 28.5% versus a gain of 22.0%. Over five years, A leads with a +10.3% price change compared with +3.9% for IQV. Agilent Technologies is the larger company by market cap ($47.68 billion vs $42.48 billion), about 1.1 times the size.
On valuation, IQVIA trades at a lower forward P/E (17.9x vs 25.0x for Agilent Technologies). Agilent Technologies pays a dividend yielding 0.60%, while IQVIA does not currently pay one. Agilent Technologies converts more of its revenue into profit, with a net margin of 18.8% versus 8.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | A | IQV |
|---|---|---|
| Share price | $169.09 | $258.11 |
| Market cap | $47.68B | $42.48B |
| 1-day change | -0.14% | -0.72% |
| YTD return | +24.27% | +14.51% |
| 1-year return | +22.03% | +28.50% |
| 5-year return | +10.32% | +3.89% |
| P/E ratio (TTM) | 33.35 | 32.30 |
| Forward P/E | 25.02 | 17.87 |
| EPS (TTM) | $5.07 | $7.99 |
| Dividend yield | 0.60% | 0.00% |
| Annual dividend | $1.01 | $0.00 |
| Revenue (latest FY) | $6.95B | $16.31B |
| Revenue growth (YoY) | +6.73% | +5.87% |
| Net income (latest FY) | $1.30B | $1.36B |
| Gross margin | 52.43% | 33.29% |
| Operating margin | 21.29% | 13.38% |
| Net margin | 18.75% | 8.34% |
| 52-week high | $177.05 | $277.40 |
| 52-week low | $108.35 | $154.50 |
| Distance from 52-week high | -4.50% | -6.95% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +4.38% | +12.68% |
| Average volume | 2.26M | 1.44M |
| Shares outstanding | 281.97M | 164.60M |
| Employees | 18,200 | 94,000 |
| Sector | Industrials | Health Care |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Commercial Physical & Biological Resarch |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Agilent Technologies is more profitable, keeping 18.8 cents of every revenue dollar as net income versus 8.3 cents for IQVIA.
- The two companies sit in different sectors: Agilent Technologies in Industrials and IQVIA in Health Care.
About Agilent Technologies
A stock →Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
Industrials · Biotechnology: Laboratory Analytical Instruments · 18,200 employees
About IQVIA
IQV stock →IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 94,000 employees
A vs IQV FAQ
Which is bigger, Agilent Technologies or IQVIA?
Agilent Technologies (A) is larger, with a market capitalization of $47.68B compared with $42.48B for IQVIA (IQV).
Which stock has performed better over the past year, A or IQV?
IQV returned +28.50% over the past 12 months, compared with +22.03% for A (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, A or IQV?
IQV has the lower trailing P/E at 32.3, versus 33.4 for A. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Agilent Technologies or IQVIA?
Agilent Technologies pays a dividend yielding 0.60%, while IQVIA does not currently pay a regular dividend.
Are Agilent Technologies and IQVIA in the same industry?
No. Agilent Technologies is in the Industrials sector, while IQVIA is in Health Care.